| Trial ID: | L2929 |
| Source ID: | NCT00940472
|
| Associated Drug: |
Dmmet-01
|
| Title: |
Study on DMMET-01 Versus Metformin on Improvement of Metabolic Control in Naive Type 2 Diabetes Patients
|
| Acronym: |
DMMET2
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Type 2
|
| Interventions: |
DRUG: DMMET-01|DRUG: Metformin Hydrochloride
|
| Outcome Measures: |
Primary: Metabolic Control (Fasting glucose, postprandial glucose, HbA1C), 3 months | Secondary: Lipid Profile (Total cholesterol, HDL, LDL, triglycerides), 3 months|Adverse Events, 4 months
|
| Sponsor/Collaborators: |
Sponsor: Laboratorios Silanes S.A. de C.V.
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE2|PHASE3
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-03
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2010-05-18
|
| Locations: |
Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jal, 44340, Mexico
|
| URL: |
https://clinicaltrials.gov/show/NCT00940472
|
